We are live on ! Find out more
TC

Truvestments Capital Portfolio holdings

AUM $554M
1-Year Est. Return 32.49%
This Fund
S&P 500
This Quarter Est. Return
+6.97%
1 Year Est. Return
+32.49%
3 Year Est. Return
+86.71%
5 Year Est. Return
+90.42%
10 Year Est. Return
AUM
$373M
AUM Growth
+$122M
Cap. Flow
+$104M
Cap. Flow %
27.84%
Top 10 Hldgs %
28.98%
Holding
934
New
711
Increased
160
Reduced
58
Closed

Sector Composition

Rank Sector Weight
1 Technology 27.88%
2 Financials 12.94%
3 Industrials 12.22%
4 Real Estate 9.69%
5 Healthcare 6.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RNAM
876
DELISTED
Avidity Biosciences
RNAM
$459 ﹤0.01%
+10
New +$434
CSTE icon
877
Caesarstone
CSTE
$88.2M
$456 ﹤0.01%
+100
New +$504
CCSI icon
878
Consensus Cloud Solutions
CCSI
$678M
$447 ﹤0.01%
+19
New +$397
INUV icon
879
Inuvo
INUV
$16.8M
$429 ﹤0.01%
+174
New +$486
OPEN icon
880
Opendoor
OPEN
$3.38B
$400 ﹤0.01%
+207
New +$420
DTM icon
881
DT Midstream
DTM
$13.7B
$393 ﹤0.01%
+5
New +$373
POOL icon
882
Pool Corp
POOL
$7.27B
$377 ﹤0.01%
+1
New +$346
THTX
883
DELISTED
Theratechnologies
THTX
$370 ﹤0.01%
+298
New +$404
PSA icon
884
Public Storage
PSA
$60.8B
$364 ﹤0.01%
+1
New +$325
FMST
885
Foremost Lithium Resource & Technology
FMST
$22.4M
$356 ﹤0.01%
+125
New +$366
SENS icon
886
Senseonics Holdings Inc
SENS
$399M
$350 ﹤0.01%
+50
New +$403
GRAL
887
GRAIL Inc
GRAL
$3.34B
$344 ﹤0.01%
+25
New +$379
DNOW icon
888
DNOW Inc
DNOW
$3.01B
$323 ﹤0.01%
+25
New +$330
ABEO icon
889
Abeona Therapeutics
ABEO
$425M
$322 ﹤0.01%
+51
New +$266
PD icon
890
PagerDuty
PD
$916M
$315 ﹤0.01%
+17
New +$332
OXY icon
891
Occidental Petroleum
OXY
$58.6B
$309 ﹤0.01%
+6
New +$342
CAN
892
Canaan Creative
CAN
$149M
$308 ﹤0.01%
+305
New +$303
SAGE
893
DELISTED
Sage Therapeutics
SAGE
$282 ﹤0.01%
+39
New +$357
VMEO
894
DELISTED
Vimeo
VMEO
$278 ﹤0.01%
+55
New +$250
SAFE
895
Safehold
SAFE
$1.09B
$262 ﹤0.01%
+10
New +$236
GLDM icon
896
SPDR Gold MiniShares Trust
GLDM
$30B
$261 ﹤0.01%
+5
New +$246
SFIX
897
Stitch Fix
SFIX
$530M
$257 ﹤0.01%
+91
New +$354
PVLA
898
Palvella Therapeutics
PVLA
$2.19B
$232 ﹤0.01%
+14
New +$205
CBIO
899
Crescent Biopharma
CBIO
$644M
$221 ﹤0.01%
+13
New +$273
EDIT icon
900
Editas Medicine
EDIT
$432M
$208 ﹤0.01%
+61
New +$266

Similar funds

Truvestments Capital's Q3 2024 Portfolio in Review

As of Q3 2024, Truvestments Capital held 934 positions worth $373M, up 49% from $251M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Truvestments Capital deployed $104M of net new capital in Q3 2024, opening 711 new positions and adding to 160 existing holdings. Its largest new stake was Invesco S&P 500 Top 50 ETF: 80,226 shares worth $3.81M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 29% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was KLA, an estimated $470K trimmed.

  • Truvestments Capital's largest Q3 2024 buy was Invesco S&P 500 Top 50 ETF: 80,226 shares worth $3.81M.
  • Truvestments Capital added most to Berkshire Hathaway Class B in Q3 2024, an estimated $16.7M increase.
  • Truvestments Capital's biggest Q3 2024 reduction was KLA, cutting an estimated $470K.
  • Truvestments Capital's ten largest holdings make up 29% of its $373M portfolio in Q3 2024.
  • Truvestments Capital opened 711 new positions and closed 0 in Q3 2024.
  • Truvestments Capital's portfolio value rose 49% quarter-over-quarter to $373M.

Based on Truvestments Capital's 13F filing for Q3 2024, filed 13 Nov 2024.